This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovations of Clarence Williams, Jr.
Introduction
Clarence Williams, Jr. is a notable inventor based in Riverdale, NY (US). He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies. His work is crucial for advancing diagnostic and therapeutic techniques in cancer treatment.
Latest Patents
Williams holds a patent for hybridoma cell lines that produce monoclonal antibodies. Specifically, his monoclonal antibody 100-310 has been found to be reactive against colon cancer cells. This innovation is particularly valuable for diagnostic imaging and treatment of colon cancer, showcasing the potential impact of his work on patient care.
Career Highlights
He is currently affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His role at this prestigious center allows him to contribute to groundbreaking research that can change the landscape of cancer diagnostics and therapies.
Collaborations
Williams has collaborated with esteemed colleagues such as Sydney Welt and Elsje C Barendswaard. These partnerships enhance the research environment and foster innovation in the field of cancer treatment.
Conclusion
Clarence Williams, Jr. exemplifies the spirit of innovation in medical research, particularly through his work on monoclonal antibodies for colon cancer. His contributions are vital for improving diagnostic and therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile